UK vs EU Cosmetics Regulation After Brexit: A Practical Guide for Brands Entering Both Markets

The question comes up almost every week in our team’s calls with European cosmetics brands: should we enter the UK market before or alongside the EU? Four years after Brexit implementation, many manufacturers still assume their EU compliance package transfers to Great Britain with minimal adjustment. It doesn’t — and the regulatory gap between Great Britain and the EU27 is actively widening.

Here’s what the divergence actually looks like in practice, and how to structure your market entry so you’re not paying for the same compliance work twice.

What Changed on 1 January 2021 — and What’s Still Changing

The UK retained EU Regulation 1223/2009 as domestic law through the European Union (Withdrawal) Act 2018, creating what’s informally called the “UK Cosmetics Regulation.” At the moment of exit, the two frameworks were functionally identical. Since then, they’ve diverged — not dramatically, but in ways that matter for formulation, labeling, and supply chain documentation.

The UK’s Office for Product Safety and Standards (OPSS), operating under the Department for Business and Trade, now acts as the de facto regulatory authority for cosmetics in Great Britain. It maintains its own restricted and prohibited substances annexes, updated separately from those governed by the European Commission. When the EU’s Scientific Committee on Consumer Safety (SCCS) issues a new restriction or ban, the UK doesn’t adopt it automatically. The UK Cosmetics Expert Group (UKCEG) must separately evaluate and recommend the change before UK law follows.

In concrete terms, this means colorant approvals can now differ between EU Annex IV and its UK equivalent, and restrictions on certain titanium dioxide uses in spray products — adopted by the EU following SCCS scientific opinion — have not been mirrored in Great Britain on the same timeline. For most product categories, the practical difference is still small. But it requires active monitoring on both sides, not a one-time compliance check at product launch.

And there’s no political appetite on either side for re-convergence. Both systems are separately funded and separately staffed. Brands that build compliance infrastructure assuming eventual re-alignment are making a bet that current evidence doesn’t support.

Responsible Person: Two Appointments, Two Sets of Obligations

Under EU Regulation 1223/2009, every cosmetic product placed on the EU or EEA market must have a Responsible Person (RP) established in the EU or EEA. That person’s name and address must appear on the label. They hold the Product Information File (PIF), manage notifications in the CPNP (Cosmetic Products Notification Portal), and bear legal liability for compliance. The CPNP is the single notification portal operated by the European Commission.

Great Britain requires an entirely separate Responsible Person established there. Northern Ireland is a crucial exception: under the Windsor Framework, Northern Ireland continues to follow EU cosmetics rules — not Great Britain’s. A product sold in Northern Ireland must have an EU/EEA Responsible Person and be notified on the CPNP, not on the Great Britain OPSS system.

So a brand selling across Great Britain, Northern Ireland, France, and Germany potentially needs:

• One EU/EEA Responsible Person covering EU27 sales and Northern Ireland
• One Great Britain Responsible Person for England, Scotland, and Wales

The UK notification system — Submit Cosmetic Product Notifications (SCPN), accessible via the OPSS portal — is entirely separate from the CPNP. Notifications made in the CPNP before 1 January 2021 did not transfer to the UK system. Brands that launched in the EU before Brexit and now want to sell in Great Britain need to re-notify every product via SCPN. As of mid-2026, that notification backlog still catches companies off guard when they start distribution arrangements with UK retailers and discover their products aren’t notified.

The cost of a dual-RP structure adds up. Retaining a UK-established RP service typically runs £800–£3,000 per year depending on portfolio size, on top of EU RP costs. That’s before accounting for PIF maintenance obligations in both jurisdictions, and the time spent coordinating documentation across two legal entities with different record-keeping access rights.

UK REACH vs EU REACH: Not Interchangeable, Not Converging

One of the more technical — and consistently misunderstood — elements of UK-EU divergence is REACH. EU REACH, administered by the European Chemicals Agency (ECHA), governs substance registration, restriction, and authorisation across the EU27. UK REACH, administered by the Health and Safety Executive (HSE), is a parallel system that came into force on 1 January 2021 and covers Great Britain only.

The two systems started from the same baseline, but they’ve diverged on substances of very high concern (SVHC), restriction proposals, and authorisation timelines. ECHA’s SVHC candidate list is updated by ECHA’s Member State Committee; the UK SVHC list is maintained separately by the HSE. As of mid-2026, the lists share most entries but differ on several recent additions — meaning a substance that triggers REACH disclosure obligations in the EU may not yet carry the same obligation in Great Britain, or vice versa.

For cosmetics specifically, REACH intersects with EU Regulation 1223/2009 wherever ingredients contain registerable substances above threshold quantities. If you’re sourcing a UV filter or fragrance ingredient that has SVHC candidate list status under EU REACH but not (yet) under UK REACH — or the reverse — your compliance documentation needs to reflect that distinction by jurisdiction, not as a single undifferentiated assertion.

This is where supplier documentation frequently fails. A supplier Certificate of Compliance (CoC) that states “REACH compliant” without specifying EU REACH or UK REACH is not useful documentation. We see this routinely in supply chain audits: a single CoC issued to cover both systems when the actual compliance status differs between them. Your procurement team should request jurisdiction-specific REACH declarations as a standard requirement in supplier qualification.

Labeling: One SKU or Two?

Labeling requirements between EU and UK cosmetics regulation are substantially similar. Both require the Responsible Person’s name and address, INCI ingredient listing, net content, best-before date where applicable, special precautions, product function, and batch code. The key physical difference: the GB RP address on the label must be a Great Britain address, not an EU address. A French RP address does not satisfy the UK requirement.

That sounds minor, but it has real production implications. A brand producing a single SKU for both markets must either:

• Maintain two label variants (EU RP address vs GB RP address), which doubles label artwork management and creates version control risks
• Use a secondary label or sticker for one market, which works legally in many cases but occasionally creates issues with UK Trading Standards inspectors looking for “applied after manufacture” labeling

Multi-language requirements add another layer. In the EU, labeling must be in the official language(s) of the member state(s) where the product is sold — French for France, German for Germany, Italian for Italy. In Great Britain, English is sufficient for all practical purposes. For a brand targeting France, Germany, and the UK simultaneously, you’re managing at minimum three language versions if you consolidate labels, or two label SKUs with multi-language EU and a GB-English-only variant.

The dual-market labeling decision is worth a dedicated structural analysis before your first production run. Brands that solve it early save substantially on re-labeling costs at scale.

Which Market to Enter First: A Working Framework

There’s no universal answer, but a few factors should drive the decision consistently.

Enter the EU first if:

• Your primary target consumers are in France, Germany, Spain, or Italy — the four largest EU cosmetics markets, which together account for approximately 65% of total EU cosmetics consumption
• Your formulation uses ingredients under active SCCS evaluation, where EU safety data requirements and qualified assessor networks are more established
• You already work with an ISO 22716-certified manufacturing facility whose QMS documentation is structured around EU competent authority expectations

Enter the UK first if:

• You have a distribution partner already established in Great Britain who can hold RP obligations and warehouse stock
• Your product categories sit in areas where UK restricted substance lists are currently narrower than EU equivalents, giving you more formulation flexibility at launch
• You want a single-language, single-currency market to validate consumer claims and gather performance data before a larger EU rollout

The integrated dual-market approach is operationally harder but commercially logical for brands with adequate resources. The documentation overhead for a simultaneous UK and EU launch is roughly 40% more than a single-market launch — not double — because the safety assessment toxicology, PIF core content, and efficacy claims documentation is shared. The divergence sits at the Responsible Person structure, notification submissions, and substance compliance level, not in the underlying safety science. So the incremental cost is real but manageable if planned from the start.

What consistently creates the most cost is retrofitting. Brands that launch in the EU without structuring their compliance infrastructure for potential UK expansion typically spend 60–80% of a fresh dual-market compliance build when they eventually add Great Britain to their distribution. The PIF isn’t the problem — it’s the RP contracts, the SCPN re-notifications for an existing product portfolio, the label artwork revisions, and the supplier CoC re-requests.

Before You Appoint Your Responsible Persons

A few things that get overlooked at the RP selection stage and create problems 12–18 months later.

The RP must genuinely hold the PIF — not just be listed as the contact. For the EU, the PIF must be accessible to competent authorities in the member state where the RP is established. For Great Britain, it must be accessible in Great Britain. Letterbox RP services that don’t actually maintain file access expose you in an inspection, and competent authority spot checks in France (DGCCRF) and Germany (BAuA) do happen.

CPNP and SCPN submissions both require accurate product category data and RP details at submission. Errors mean rejection and re-submission — which delays a product launch by 2–4 weeks in practice. Running a pre-submission review on notification data before lodging saves that delay.

And safety assessor qualifications matter on both sides. EU Regulation 1223/2009 Annex I specifies the qualifications required for the person signing the safety assessment — pharmacy, medicine, toxicology, or a related discipline with demonstrated competence. The UK framework mirrors this, but the practical recognition of specific qualifications can differ between OPSS and EU competent authorities. If your assessor is EU-qualified and you’re relying on a single safety assessment document for both markets, confirm that their credentials satisfy both frameworks before the document is finalised.

---

The UK and EU cosmetics regulatory environments are not converging. Both are actively maintained, separately governed, and moving on independent legislative timetables. Building your compliance infrastructure for one and hoping it covers the other is a plan that works right up until it doesn’t — usually at the point of a retailer audit or a competent authority inspection.

If you’re currently operating from a single-market compliance file and planning expansion into both jurisdictions, a regulatory gap analysis before your next product launch is a genuinely good investment.

---

Written by Nour Abochama, Quality & Regulatory Advisor, Care Europe | VP Operations, Qalitex. Learn more about our team

Talk to our team about EU market entry. Contact us

Related from our network

• US FDA Compliance Support for European Cosmetics Exporters — ISO 17025-accredited laboratory testing and regulatory support for European brands entering the American market
• Health Canada Compliance for European Natural Health and Cosmetics Brands — Canadian regulatory pathway guidance for EU manufacturers expanding into the Canadian market